pamidronate and Albers-Schoenberg Disease studies

pamidronate and Albers-Schoenberg Disease

Research Excerpts

Excerpt	Relevance	Reference
"Sixty-two (52."	1.33	Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. ( Broumand, V; Fortin, M; Marx, RE; Sawatari, Y, 2005)

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	6 (75.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

1 (12.50)

18.2507

2000's

6 (75.00)

29.6817

2010's

1 (12.50)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Wehrhan, F	1
Hyckel, P	1
Amann, K	1
Ries, J	1
Stockmann, P	1
Schlegel, K	1
Neukam, F	1
Nkenke, E	1
Whyte, MP	1
Wenkert, D	1
Clements, KL	1
McAlister, WH	1
Mumm, S	1
Glorieux, FH	1
Rauch, F	1
Shapiro, JR	1
Bjarnason, NH	1
Tanvetyanon, T	1
Ward, K	1
Cowell, CT	1
Little, DG	1
Marx, RE	1
Sawatari, Y	1
Fortin, M	1
Broumand, V	1
Rawlinson, PS	1
Green, RH	1
Coggins, AM	1
Boyle, IT	1
Gibson, BE	1

Studies

Wehrhan, F

Hyckel, P

Amann, K

Ries, J

Stockmann, P

Schlegel, K

Neukam, F

Nkenke, E

Whyte, MP

Wenkert, D

Clements, KL

McAlister, WH

Mumm, S

Glorieux, FH

Rauch, F

Shapiro, JR

Bjarnason, NH

Tanvetyanon, T

Ward, K

Cowell, CT

Little, DG

Marx, RE

Sawatari, Y

Fortin, M

Broumand, V

Rawlinson, PS

Green, RH

Coggins, AM

Boyle, IT

Gibson, BE

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation[NCT02074631]	Phase 2	80 participants (Actual)	Interventional	2015-02-28	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation[NCT02074631]

Phase 2

80 participants (Actual)

Interventional

2015-02-28

Completed

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

8 other studies available for pamidronate and Albers-Schoenberg Disease

Article	Year
Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment. Oral diseases, 2011, Volume: 17, Issue:4 Topics: Alkaline Phosphatase; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Morphogen	2011
Bisphosphonate-induced osteopetrosis. The New England journal of medicine, 2003, Jul-31, Volume: 349, Issue:5 Topics: Alkaline Phosphatase; Bone Density; Bone Marrow; Calcium; Child; Diphosphonates; Humans; Male; Osteo	2003
Bisphosphonates in children with bone diseases. The New England journal of medicine, 2003, Nov-20, Volume: 349, Issue:21 Topics: Animals; Bone Density; Child; Diphosphonates; Humans; Knee Joint; Male; Osteogenesis Imperfecta; Ost	2003
Bisphosphonates in children with bone diseases. The New England journal of medicine, 2003, Nov-20, Volume: 349, Issue:21 Topics: Bone Density; Bone Resorption; Child; Diphosphonates; Drug Administration Schedule; Humans; Ibandron	2003
Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. Journal of the National Cancer Institute, 2005, Jan-05, Volume: 97, Issue:1 Topics: Analgesics; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Fractures, Bone; Humans; Imidazol	2005
Quantification of metaphyseal modeling in children treated with bisphosphonates. Bone, 2005, Volume: 36, Issue:6 Topics: Adolescent; Bone Development; Bone Diseases; Child; Child, Preschool; Diphosphonates; Female; Femur;	2005
Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2005, Volume: 63, Issue:11 Topics: Abscess; Alendronate; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breas	2005
Malignant osteopetrosis: hypercalcaemia after bone marrow transplantation. Archives of disease in childhood, 1991, Volume: 66, Issue:5 Topics: Bone Marrow Transplantation; Calcitonin; Child, Preschool; Diphosphonates; Female; Humans; Hypercalc	1991

Article

Year

Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment.

Oral diseases, 2011, Volume: 17, Issue:4

Topics: Alkaline Phosphatase; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Morphogen

2011

Bisphosphonate-induced osteopetrosis.

The New England journal of medicine, 2003, Jul-31, Volume: 349, Issue:5

Topics: Alkaline Phosphatase; Bone Density; Bone Marrow; Calcium; Child; Diphosphonates; Humans; Male; Osteo

2003

Bisphosphonates in children with bone diseases.

The New England journal of medicine, 2003, Nov-20, Volume: 349, Issue:21

Topics: Animals; Bone Density; Child; Diphosphonates; Humans; Knee Joint; Male; Osteogenesis Imperfecta; Ost

2003

Bisphosphonates in children with bone diseases.

The New England journal of medicine, 2003, Nov-20, Volume: 349, Issue:21

Topics: Bone Density; Bone Resorption; Child; Diphosphonates; Drug Administration Schedule; Humans; Ibandron

2003

Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.

Journal of the National Cancer Institute, 2005, Jan-05, Volume: 97, Issue:1

Topics: Analgesics; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Fractures, Bone; Humans; Imidazol

2005

Quantification of metaphyseal modeling in children treated with bisphosphonates.

Bone, 2005, Volume: 36, Issue:6

Topics: Adolescent; Bone Development; Bone Diseases; Child; Child, Preschool; Diphosphonates; Female; Femur;

2005

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2005, Volume: 63, Issue:11

Topics: Abscess; Alendronate; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breas

2005

Malignant osteopetrosis: hypercalcaemia after bone marrow transplantation.

Archives of disease in childhood, 1991, Volume: 66, Issue:5

Topics: Bone Marrow Transplantation; Calcitonin; Child, Preschool; Diphosphonates; Female; Humans; Hypercalc

1991